The 2NN study - CD8 T cells
The 2NN study - CD8 T cells
The 2NN study - CD8 T cells
SHOW LESS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
% of patients<br />
100<br />
75<br />
50<br />
25<br />
0<br />
Treatment success and failure<br />
29.1 22.0 20.0 34.5<br />
11.4<br />
18.9<br />
15.3<br />
16.3<br />
56.4 56.3 62.3 46.9<br />
NVP-od NVP-bd EFV NVP+EFV<br />
failure component:<br />
(w hichever comes first)<br />
change Rx<br />
disease progression<br />
virologic<br />
success<br />
Success: only significant difference: EFV vs NVP+EFV, p< 0.001<br />
Frank van Leth 8
Change language